相关实验视频

Updated: Jun 15, 2025

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

HLA和鼻多重症易感性:对全球研究的元分析

Ryan Witcher¹, Sugosh M Anur², Dylan Thibaut¹

¹Lake Erie College of Osteopathic Medicine, Bradenton, FL, USA.

The Annals of otology, rhinology, and laryngology

|August 23, 2024

概括

这项研究发现,特定的人类白细胞抗原 (HLA) II类等位基因,HLA-DQA1*0201和HLA-DRB1*7,与患鼻多重症 (NP) 的风险增加有关. 这些遗传因素可能在病情中起作用.

科学领域:

免疫遗传学免疫遗传学
耳鼻喉科耳鼻喉科耳鼻喉科
遗传流行病学遗传流行病学

背景情况:

鼻多重症 (NP) 是一种普遍存在的鼻状况,影响患者的生活质量.
NP病理生理学涉及复杂的遗传,环境和免疫因素.
之前对人类白细胞抗原 (HLA) II 类等位基因和NP 风险的研究已经产生了相互矛盾的结果.

研究的目的:

进行元分析,研究特定的HLAII类等位基因 (HLA-DQA1,HLA-DQB1,HLA-DRB1) 与鼻多重症风险之间的关联.
澄清现有文献中关于HLAII类等位基因和NP的相互矛盾的发现.

主要方法:

电子数据库的系统审查 (PubMed,谷歌学者,科克兰图书馆).
纳入/排除标准用于确定符合条件的研究.
使用随机效应模型进行元分析,以计算HLAII类等位基因和NP风险的聚合概率比率 (ORs) 和95%置信区间 (CI),并进行异质性评估 (I2 <25%).

主要成果:

包括四项研究,共计258个NP等位基因和802个对照等位基因.
HLA-DQA1*0201 (OR=3.08,95%CI [1.70, 5.59]) 和HLA-DRB1*7 (OR=2.04,95%CI [1.14,3.66]) 显示与增加的NP风险有显著的关联.
在DQA1*0201和DRB1*7分析中观察到低异质性 (I2 <0%);灵敏度分析表明小不对称.

结论:

分析提供了证据表明,HLA-DQA1*0201和HLA-DRB1*7等位基因是发展鼻多的危险因素.
这些发现增强了对NP遗传倾向的理解.
结果可能会为NP预防和治疗的新策略提供信息.

关键词:

在HLA-DQA1中.在HLA-DQB1中,它具有HLA-DQB1特征.在HLA-DRB1中,遗传学遗传学遗传学是一个人类白细胞抗原.这是一个元分析.鼻腔多重构成的情况.

更多相关视频

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas

Published on: February 28, 2019

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...